Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Effectiveness Trial (Phase IV) to Evaluate Protection of Pregnant Women by Hepatitis E Virus (HEV) Vaccine in Bangladesh and Risk Factors for Severe HEV Infection.

NCT02759991 is registered in ClinicalTrials.gov with Norwegian Institute of Public Health as lead sponsor.

NCT NCT02759991
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02759991 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Effectiveness Trial (Phase IV) to Evaluate Protection of Pregnant Women by Hepatitis E Virus (HEV) Vaccine in Bangladesh and Risk Factors for Severe HEV Infection.
Lead sponsor
Norwegian Institute of Public Health
Phase
Phase 4
Overall status
Completed
Start date
October 2, 2017
Completion date
September 30, 2019
Enrollment
19,460 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

hepatitis e infection